Trials / Completed
CompletedNCT05069714
One or Two Week Methotrexate Discontinuation on Efficacy of Influenza Vaccination in Rheumatoid Arthritis.
Effect of One-week vs Two-week Discontinuation of Methotrexate on Efficacy of Seasonal Influenza Vaccination in Patients With Rheumatoid Arthritis: A Randomized Clinical Trial
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 184 (actual)
- Sponsor
- Seoul National University Hospital · Academic / Other
- Sex
- All
- Age
- 19 Years
- Healthy volunteers
- Accepted
Summary
This is a multi-center, randomized, single-blinded, prospective, parallel group intervention study to investigate whether methotrexate (MTX) discontinuation for 1 week is non-inferior to MTX discontinuation for 2 weeks in regard to satisfactory vaccination response to a seasonal influenza.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | MTX-hold | Temporary discontinuation of methotrexate for 1 or 2 weeks |
Timeline
- Start date
- 2021-10-01
- Primary completion
- 2022-09-30
- Completion
- 2022-09-30
- First posted
- 2021-10-06
- Last updated
- 2022-12-16
Locations
3 sites across 1 country: South Korea
Source: ClinicalTrials.gov record NCT05069714. Inclusion in this directory is not an endorsement.